78
KURESHY ET AL.
6.62–6.66 (m, 2 H), 7.01–7.09 (m, 2 H), 7.15–7.22 (m, 10 0.97–1.15 (m, 1 H), 1.24–1.50 (m, 3 H), 1.68–1.78 (m, 2 H),
H) ppm. 13C NMR (125 MHz, CDCl3): 55.7, 66.2, 78.1, 2.04–2.16 (m, 2 H), 2.85 (bs, 1 H), 3.07–3.19 (m, 1 H),
114.7, 115.8, 126.7, 127.3, 127.8, 127.9, 128.5, 128.7, 140.3, 3.34–3.46 (m, 1 H), 3.83 (s, 3 H), 6.63–6.89 (m, 4 H) ppm;
140.7, 141.4, 152.6 ppm. IR (in KBr): 3483, 3393, 13C NMR (125 MHz, CDCl3): d 5 24.2, 25.0, 31.5, 33.0,
3026, 2964, 2833, 1807, 1510, 1453, 1254, 1024, 819, 753, 55.4, 55.6, 74.5, 109.7, 111.4, 117.2, 121.2, 137.5, 147.5
700 cm21
.
ppm. IR (in KBr): 3616, 3429, 3067, 2964, 1602, 1511, 1456,
1430, 1341, 1247, 1180, 1121, 1050, 1030, 977, 945 cm21
.
(1S,2S)-1,2-Diphenyl-2-(4-methyl-phenylamino)-
ethanol19,20
The title compound was isolated by col-
.
(1S,2S)-2-(4-Methoxyphenylamino)-cyclohexane-
1-ol19,20
The title compound was isolated by column
.
umn chromatography (n-hexane/AcOEt 90/10) as a white
solid. Melting point: 858C.19 ee > 99% on HPLC (Chiralpak
AD column,) mobile phase, 85/15 n-hexane/i-PrOH; flow
rate 1 ml/min, k 5 247 nm, tR (1R,2R) 5 20.60 min, tR
(1S,2S) 5 17.99 min. LC-MS, m/z 304 [M 1 H]1, 286
chromatography (n-hexane/AcOEt 85/15) as a white solid.
Melting point: 62–648C.19 ee 36% on HPLC (Chiralpak OD
column) mobile phase, 80/20 n-hexane/i-PrOH; flow rate
0.5 ml/min, k 5 247 nm, tR (1S,2S) 5 22.30 min, tR
1
(1R,2R): 27.48 min. [a]2D7 5 140.1 (c 5 3.2, CH2Cl2). H
(base peak) [M 2 OH]1. H NMR (500 MHz, CDCl3): d
1
NMR (500 MHz, CDCl3): d 5 0.85–1.10 (m, 1 H), 1.12–
1.40 (m, 3 H), 1.60–1.80 (m, 2 H), 2.0–2.18 (m, 2 H), 2.92–
3.04 (m, 1 H), 2.60 (bs, 1 H), 3.24–3.55 (m, 1 H), 3.73 (s, 3
H), 6.66 (d, J 5 8.8 Hz, 2 H), 6.76 (d, J 5 8.8 Hz, 2 H)
ppm; 13C NMR (125 MHz, CDCl3): d 5 24.2, 25.0, 31.4,
33.0, 55.6, 61.6, 74.3, 114.7, 116.3, 141.5, 152.8 ppm. IR (in
KBr): 3677, 3529, 3366, 3021, 3013, 2938, 2861, 2836, 1612,
1512, 1465, 1450, 1401, 1296, 1239, 1221, 1180, 1136, 1067,
5 2.15 (s, 3 H), 4.45 (d, J 5 6.2 Hz, 1 H), 4.81 (d, J 5 6.2
Hz, 1 H), 6.42–6.46 (m, 2 H), 6.84–6.88 (m, 2 H), 7.19–7.23
(m, 10 H) ppm. 13C NMR (125 MHz, CDCl3): 20.3, 65.2,
78.0, 114.4, 126.5, 127.2, 127.6, 128.1, 128.3, 129.5, 139.3,
139.5.4, 146.5 ppm. IR (in KBr): 3399, 3061, 3029,
2859, 2831, 1813, 1616, 1518, 1490, 1259, 1044, 815, 768,
700 cm21
.
(2S,3S)-2-N-Phenylamino-3-butanol20,24
.
The title
1038 cm21
.
compound was isolated by column chromatography (n-
hexane/AcOEt 90/10) as an oil. ee 19% on HPLC (Chir-
alpak OD column) mobile phase, 97.5/2.5 n-hexane/i-
PrOH; flow rate 1 ml/min, k 5 247 nm, tR (2S,3S) 5 35.63
min, tR (2R,3R) 5 38.57 min. LC-MS, m/z 166 [M 1 H]1,
1H NMR (500 MHz, CDCl3): d 5 1.14 (d, J 5 6.8 Hz, 1H),
1.25 (d, J 5 6.8 Hz, 3H), 2.61 (brs, 1H), 3.31 (m, 1H), 3.62
(m, 2H), 6.66–6.74 (m, 3H), 7.15–7.18 (m, 2H) ppm. 13C
NMR (125 MHz, CDCl3): d 5 17.3, 19.5, 56.1, 71.4, 114.3,
118.2, 129.3, 147.7 ppm. IR (KBr) 3398, 3053, 2974, 2926,
1922, 1602, 1505, 1439, 1376, 1318, 1254, 1005, 902, 751,
(1S,2S)-2-(4-Methylphenylamino)-cyclohexane-
1-ol19,20
The title compound was isolated by column
.
chromatography (n-hexane/AcOEt 90/10) as a brownish
liquid. ee 38% on HPLC (Chiralpak OD column) mobile
phase, 90/10 n-hexane/i-PrOH; flow rate 0.8 ml/min, k 5
247 nm, tR (1S,2S):17.99 min, tR (1R,2R): 20.60 min. 1H
NMR (500 MHz, CDCl3); d 5 1.01–1.05 (m, 2H), 1.23–1.40
(m, 5 H), 1.70–1.75 (m, 2 H), 2.24 (s, 3 H), 3.062–3.10 (m,
1 H), 6.64 (d, 2 H, J 5 8 Hz), 7.00 (d, 2 H, J 5 8 Hz) ppm;
13C NMR (125 MHz, CDCl3): d 5 20.40, 24.31, 25.11,
31.60, 33.10, 60.73, 74.55, 114.81, 129.88 ppm. IR (in KBr):
3665, 3390, 3105, 3019, 2928, 2860, 2734, 1866, 1617, 1519,
692 cm21
(1S,2S)-2-(Phenylamino)-cyclohexane-1-ol19,20
.
.
The 1451, 1451, 1405, 1300, 1252, 1182, 1128, 1066, 936 cm21
.
title compound was isolated by column chromatography
(n-hexane/AcOEt 90/10) as a white solid. Melting point:
58–608C.19 ee 67% on HPLC (Chiralpak OJ column) mobile
phase, 95/5 n-hexane/i-PrOH; flow rate 0.4 ml/min, k 5
247 nm, tR (1S,2S) 5 13.73 min, tR (1R,2R) 5 15.38 min.
LC-MS, m/z 192 [M 1 H]1, 214 [M 1 Na]1. 1H NMR
(500 MHz, CDCl3): d 5 1.03–1.41 (m, 4 H), 1.71–1.77 (m,
2 H), 2.09–2.15 (m, 2 H), 2.89 (m, 2 H), 3.13 (ddd, J 5 3.9
Hz, J 5 10.0 Hz, J 5 10.1 Hz, 1 H), 3.33 (ddd, J 5 4.2 Hz, J
5 10.4 Hz, J 5 10.5 Hz, 1 H), 6.7–7.2 (m, 2 H), 7.21–7.25
(m, 5 H); 13C NMR (125 MHz, CDCl3): d 5 24.2, 24.9,
31.5, 33.1, 60.1, 74.4, 114.3, 118.3, 129.3, 147.8. IR
(in KBr): 3354, 2931, 2858, 1602, 1501, 1448, 1320, 1067,
(1S,2S)-2-(Phenylamino)-cyclooctane-1-ol4,20
.
The
title compound was isolated by column chromatography
(n-hexane/AcOEt 90/10) as a white solid. Melting point
55–568C.20 ee 46% on HPLC (Chiralpak OD column) mo-
bile phase, 95/5 n-hexane/i-PrOH; flow rate 0.8 ml/min, k
5 247 nm, tR (1S,2S) 5 27.12 min, tR (1R,2R) 5 29.34 min.
1
LC-MS, m/z 218 [M 1 H]1; H NMR (500 MHz, CDCl3):
1.05–1.45 (m, 4H), 1.50–2.15 (m, 8H), 3.40–3.50 (m, 1H),
3.60–3.70 (m, 1H), 4.50 (br, 1H), 6.70–7.20 (m, 6H) ppm.
IR (KBr): 3315, 3107, 3054, 3027, 2941, 1923, 1690, 1604,
1498, 1465, 1306, 1256 cm21
.
748 cm21
.
RESULTS AND DISCUSSION
(1S,2S)-2-(2-Methoxyphenylamino)-cyclohexane-
The active catalysts for the asymmetric epoxide ring-
. The title compound was isolated by column opening reaction with anilines as nucleophile were gener-
1-ol19,20
chromatography (n-hexane/AcOEt 90/10) as a white solid. ated in situ by the reaction of poly-[(R,R)-N,N0-bis-{3-(1,1-
Melting point: 68–708C.19 ee 29% on HPLC (Chiralpak OJ dimethylethyl)-5-methylene salicylidene} cyclohexane-1,2-
column) mobile phase, 80/20 n-hexane/i-PrOH; flow rate diamine]-1/(1R,2R)-N,N0-bis[3,5-di(tert-butyl)salicyliden]
0.5 ml/min, k 5 247 nm, tR (1S,2S) 5 20.54 min, tR cyclohexane-1,2-diamine-2 with Ti(OiPr)4 (Fig. 1). To
(1R,2R) 5 22.05 min. [a]2D7 5 149.6 (c 5 3.0, CH2Cl2, 63% begin with we have carried out ring opening of meso-stil-
1
ee).1H NMR (500 MHz, CDCl3): H NMR (CDCl3): d 5 bene oxide (3) taken as model substrate with aniline (4)
Chirality DOI 10.1002/chir